A device long used by adults to manage migraines was now available for children as young as eight years old, offering new ...

AbbVie received Food and Drug Administration approval of Emblaveo, an intravenous antibiotic, for treatment of adults with complicated intra-abdominal infections with limited or no treatment options.

Roche’s subsidiary Genentech has shared positive Phase III data with the US Food and Drug Administration (FDA) as the company ...

AbbVie said that the U.S. Food and Drug Administration approved its drug for complicated intra-abdominal infections on Friday ...